K. Witt

2.4k total citations · 1 hit paper
44 papers, 1.9k citations indexed

About

K. Witt is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, K. Witt has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 13 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in K. Witt's work include Neuropeptides and Animal Physiology (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Alzheimer's disease research and treatments (8 papers). K. Witt is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Alzheimer's disease research and treatments (8 papers). K. Witt collaborates with scholars based in United States. K. Witt's co-authors include Karin E. Sandoval, Thomas P. Davis, Karen S. Mark, Jason D. Huber, Richard D. Egleton, Sharon Hom, Terrence J. Gillespie, A. Michael Crider, Susan A. Farr and John E. Morley and has published in prestigious journals such as PLoS ONE, Brain Research and The FASEB Journal.

In The Last Decade

K. Witt

41 papers receiving 1.9k citations

Hit Papers

Blood-brain barrier tight junction permeability and ische... 2008 2026 2014 2020 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Witt United States 17 897 739 307 249 230 44 1.9k
Fuyuko Takata Japan 27 1.4k 1.5× 722 1.0× 293 1.0× 392 1.6× 244 1.1× 51 2.6k
Vincent Bérézowski France 25 804 0.9× 880 1.2× 238 0.8× 244 1.0× 330 1.4× 49 2.5k
Tsuyoshi Nishioku Japan 26 654 0.7× 624 0.8× 206 0.7× 290 1.2× 212 0.9× 43 1.8k
Shinsuke Nakagawa Japan 23 1.5k 1.7× 845 1.1× 352 1.1× 308 1.2× 170 0.7× 45 2.9k
Miguel Ángel Burguillos Spain 21 800 0.9× 828 1.1× 263 0.9× 302 1.2× 113 0.5× 33 2.1k
Pallab Bhattacharya India 29 475 0.5× 869 1.2× 187 0.6× 308 1.2× 361 1.6× 113 2.3k
Lidia García‐Bonilla United States 24 1.2k 1.4× 796 1.1× 207 0.7× 302 1.2× 386 1.7× 41 2.5k
Guohong Li United States 18 1.3k 1.5× 914 1.2× 177 0.6× 137 0.6× 563 2.4× 36 2.6k
Cameron Lenahan China 30 626 0.7× 1.1k 1.4× 289 0.9× 274 1.1× 292 1.3× 91 2.6k
Anna Carolina Carvalho da Fonseca Brazil 20 567 0.6× 780 1.1× 139 0.5× 165 0.7× 103 0.4× 40 1.9k

Countries citing papers authored by K. Witt

Since Specialization
Citations

This map shows the geographic impact of K. Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Witt more than expected).

Fields of papers citing papers by K. Witt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Witt. The network helps show where K. Witt may publish in the future.

Co-authorship network of co-authors of K. Witt

This figure shows the co-authorship network connecting the top 25 collaborators of K. Witt. A scholar is included among the top collaborators of K. Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Witt. K. Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crider, A. Michael, Karin E. Sandoval, William L. Neumann, et al.. (2024). 3-Thio-3,4,5-trisubstituted-1,2,4-triazoles: high affinity somatostatin receptor-4 agonist synthesis and structure–activity relationships. RSC Medicinal Chemistry. 16(2). 945–960. 1 indexed citations
2.
Sandoval, Karin E. & K. Witt. (2024). Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting. Pharmacological Reviews. 76(6). 1291–1325. 2 indexed citations
3.
Neumann, William L., Karin E. Sandoval, Susan A. Farr, et al.. (2021). Synthesis and structure–activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment. RSC Medicinal Chemistry. 12(8). 1352–1365. 6 indexed citations
4.
Schober, Joseph, et al.. (2021). NNC 26-9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells. PLoS ONE. 16(7). e0254242–e0254242. 8 indexed citations
5.
Sandoval, Karin E., et al.. (2018). Mfsd2a and Glut1 Brain Nutrient Transporters Expression Increase with 32-Week Low and High Lard Compared with Fish-Oil Dietary Treatment in C57Bl/6 Mice. Current Developments in Nutrition. 2(10). nzy065–nzy065. 8 indexed citations
6.
Witt, K. & Karin E. Sandoval. (2014). Steroids and the Blood–Brain Barrier. Advances in pharmacology. 71. 361–390. 51 indexed citations
7.
Sandoval, Karin E., Susan A. Farr, William A. Banks, et al.. (2010). Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. European Journal of Pharmacology. 654(1). 53–59. 19 indexed citations
8.
Sandoval, Karin E. & K. Witt. (2010). Age and 17β-estradiol effects on blood–brain barrier tight junction and estrogen receptor proteins in ovariectomized rats. Microvascular Research. 81(2). 198–205. 42 indexed citations
9.
Witt, K., et al.. (2008). Autonomous Mission Operations for Sensor Webs. AGUFM. 2008. 8 indexed citations
10.
Sandoval, Karin E. & K. Witt. (2008). Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiology of Disease. 32(2). 200–219. 797 indexed citations breakdown →
11.
Witt, K., Karen S. Mark, Karin E. Sandoval, & Thomas P. Davis. (2007). Reoxygenation stress on blood–brain barrier paracellular permeability and edema in the rat. Microvascular Research. 75(1). 91–96. 56 indexed citations
12.
Crider, A. Michael & K. Witt. (2007). Somatostatin sst4 Ligands: Chemistry and Pharmacology. Mini-Reviews in Medicinal Chemistry. 7(3). 213–220. 15 indexed citations
13.
Witt, K. & Thomas P. Davis. (2006). CNS drug delivery: Opioid peptides and the blood-brain barrier. The AAPS Journal. 8(1). E76–E88. 68 indexed citations
14.
Witt, K., Karen S. Mark, Jason D. Huber, & Thomas P. Davis. (2004). Hypoxia‐inducible factor and nuclear factor kappa‐B activation in blood–brain barrier endothelium under hypoxic/reoxygenation stress. Journal of Neurochemistry. 92(1). 203–214. 45 indexed citations
15.
Huber, Jason D., Richard D. Egleton, K. Witt, et al.. (2003). Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. Journal of Pharmaceutical Sciences. 92(7). 1377–1385. 11 indexed citations
16.
Witt, K., Jason D. Huber, Richard D. Egleton, & Thomas P. Davis. (2002). Pluronic P85 Block Copolymer Enhances Opioid Peptide Analgesia. Journal of Pharmacology and Experimental Therapeutics. 303(2). 760–767. 22 indexed citations
17.
Witt, K., Terrence J. Gillespie, Jason D. Huber, Richard D. Egleton, & Thomas P. Davis. (2001). Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. Peptides. 22(12). 2329–2343. 175 indexed citations
18.
Witt, K., Cheryl A. Slate, Richard D. Egleton, et al.. (2000). Assessment of Stereoselectivity of Trimethylphenylalanine Analogues of δ‐Opioid [D‐Pen2,D‐Pen5]‐Enkephalin. Journal of Neurochemistry. 75(1). 424–435. 32 indexed citations
19.
Witt, K., Jason D. Huber, Richard D. Egleton, & Thomas P. Davis. (2000). Insulin Enhancement of Opioid Peptide Transport across the Blood-Brain Barrier and Assessment of Analgesic Effect. Journal of Pharmacology and Experimental Therapeutics. 295(3). 972–978. 14 indexed citations
20.
Verrill, David E., et al.. (1996). Recommended Guidelines for Monitoring and Supervision of North Carolina Phase II/III Cardiac Rehabilitation Programs. Journal of Cardiopulmonary Rehabilitation. 16(1). 9–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026